[What is safe in conservative ulcer therapy? An evaluation of results from clinical studies].
D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005247:Feeding Behavior; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000628:therapy*; D010890:Pirenzepine; D011446:Prospective Studies; D012008:Recurrence; D013392:Sucralfate; D014945:Wound Healing / Q000187:drug effects
D000863:Antacids; D001570:Benzodiazepinones; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D010890:Pirenzepine; D013392:Sucralfate; D000535:Aluminum; D002229:Carbenoxolone
Was ist gesichert in der konservativen Ulcustherapie? Eine Wertung der Ergebnisse klinischer Studien.